The Current Ratio as of December 2025 (TTM) for Anthera Pharmaceuticals, Inc. (ANTH) is 0.68

According to Anthera Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 0.68. This represents a change of -69.18% compared to the average of 2.20 of the last 4 quarters.

Anthera Pharmaceuticals, Inc. (ANTH) Historical Current Ratio (quarterly & annually)

How has ANTH Current Ratio performed in the past?

The mean historical Current Ratio of Anthera Pharmaceuticals, Inc. over the last ten years is 3.07. The current 0.68 Current Ratio has changed 2.11% with respect to the historical average. Over the past ten years (40 quarters), ANTH's Current Ratio was at its highest in in the June 2010 quarter at 16.10. The Current Ratio was at its lowest in in the September 2008 quarter at 0.

Anthera Pharmaceuticals, Inc. (ANTH) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Anthera Pharmaceuticals, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Anthera Pharmaceuticals, Inc. (ANTH) Average Current Ratio

How has ANTH Current Ratio performed in the past?

The current Current Ratio of Anthera Pharmaceuticals, Inc. (ANTH) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Anthera Pharmaceuticals, Inc. (ANTH) Current Ratio vs. Peers

How is ANTH’s Current Ratio compared to its peers?

Anthera Pharmaceuticals, Inc.’s Current Ratio is less than PhaseRx, Inc. (7.99), less than Neurobiological Technologies, Inc. (35.34), greater than Synovics Pharmaceuticals, Inc. (0.53), greater than Cotinga Pharmaceuticals Inc. (0.14), less than Sienna Biopharmaceuticals, Inc. (2.07), greater than Comera Life Sciences Holdings, Inc. (0.61), greater than SheerVision, Inc. (0.49), less than GlobeImmune, Inc. (2.62), greater than OncoVista Innovative Therapies, Inc. (0.00), greater than Viveon Health Acquisition Corp. (0.00),

Build a custom stock screener for Anthera Pharmaceuticals, Inc. (ANTH) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Anthera Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Anthera Pharmaceuticals, Inc. (ANTH) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Anthera Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.